Q
Qianbin Sun
Publications - 7
Citations - 44
Qianbin Sun is an academic researcher. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 4, co-authored 7 publications receiving 44 citations.
Papers
More filters
Journal ArticleDOI
Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT–IKK/STAT3 Axis
Xiao-Ping Wang,Weili Li,Yawen Zhang,Qianbin Sun,Jingxin Cao,Nannan Tan,Shuang-wang Yang,Linghui Lu,Qian Zhang,Peng Wei,Xiao Chen Ma,Wei Wang,Yong Wang +12 more
TL;DR: Cal inhibited inflammation and fibrosis via activation of the PI3K–AKT pathway in H9C2 cells, fibroblasts, and heart failure in postacute myocardial infarction rats.
Journal ArticleDOI
Tanshinone I Inhibits Doxorubicin-Induced Cardiotoxicity by Regulating Nrf2 Signaling Pathway
Qian Jiang,Xu Chen,Xuehao Tian,Jingmei Zhang,Siming Xue,Yanyan Jiang,Tiantian Liu,Xiaoping Wang,Qianbin Sun,Yi Hong,Chun Li,Dongqing Guo,Yesong Wang,Qiyan Wang +13 more
TL;DR: Tan I (Tan I) is one of the major tanshinones isolated from Salvia miltiorrhiza and has been shown to be effective in the treatment of cardiovascular diseases as discussed by the authors .
Journal ArticleDOI
Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy
Weili Li,Xiaoping Wang,Tianhua Niu and Simin Liu,Qian Zhang,Jingxin Cao,Yabo Jiang,Qianbin Sun,Chun Li,Wei Wang,Yong Wang +9 more
TL;DR: This research documented p53-Parkin-mediated cascade of mitophagy deficiency-mitochondrial dyshomeostasis-apoptosis as a pathogenic mechanism and druggable pathway and harpagoside as a cardioprotection on DICT by acting on novel interaction between p53 and Parkin.
Journal ArticleDOI
Mechanisms and Drug Intervention for Doxorubicin-Induced Cardiotoxicity Based on Mitochondrial Bioenergetics
Guanjing Ling,Xiaoping Wang,Nannan Tan,Jingxin Cao,Weili Li,Yawen Zhang,Jinchi Jiang,Qianbin Sun,Yan Jiang,Wei Wang,Yong Wang +10 more
TL;DR: The related mechanisms of DOX-induced cardiac mitochondrial bioenergetics disorders reported in recent years are summarized, including mitochondrial substrate metabolism, the mitochondrial respiratory chain, myocardial ATP storage and utilization, and other mechanisms affecting mitochondrial bioenersgetics.
Journal ArticleDOI
Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway
Xuehao Tian,Xu Chen,Qian Jiang,Qianbin Sun,Tiantian Liu,Yi Hong,Yawen Zhang,Yanyan Jiang,Mingyan Shao,Ran Yang,Chun Li,Qiyan Wang,Yong Wang +12 more
TL;DR: NGR1 could significantly improve the heart function and myocardial injury in mice with HF and up-regulate the expression of p-AMPK in vivo and reduce cardiac lipotoxicity in vivo.